These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34254198)

  • 1. LncRNAs as putative biomarkers and therapeutic targets for Parkinson's disease.
    Taghizadeh E; Gheibihayat SM; Taheri F; Afshani SM; Farahani N; Saberi A
    Neurol Sci; 2021 Oct; 42(10):4007-4015. PubMed ID: 34254198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease.
    Jiao F; Wang Q; Zhang P; Bu L; Yan J; Tian B
    Behav Brain Res; 2017 Jul; 331():123-130. PubMed ID: 28476570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of non-coding RNAs in Parkinson's disease.
    Majidinia M; Mihanfar A; Rahbarghazi R; Nourazarian A; Bagca B; Avci ÇB
    Mol Biol Rep; 2016 Nov; 43(11):1193-1204. PubMed ID: 27492082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
    Sivagurunathan N; Ambatt ATS; Calivarathan L
    Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of Long Noncoding RNAs in Regulating Inflammasome-Mediated Neurodegeneration in Parkinson's Disease.
    Sivagurunathan N; Rahamathulla MP; Al-Dossary H; Calivarathan L
    Mol Neurobiol; 2024 Jul; 61(7):4619-4632. PubMed ID: 38105409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis.
    Riva P; Ratti A; Venturin M
    Curr Alzheimer Res; 2016; 13(11):1219-1231. PubMed ID: 27338628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Long Noncoding RNA Expression Precedes the Course of Parkinson's Disease-a Preliminary Report.
    Kraus TFJ; Haider M; Spanner J; Steinmaurer M; Dietinger V; Kretzschmar HA
    Mol Neurobiol; 2017 May; 54(4):2869-2877. PubMed ID: 27021022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALAT1 lncRNA and Parkinson's Disease: The role in the Pathophysiology and Significance for Diagnostic and Therapeutic Approaches.
    Abrishamdar M; Jalali MS; Rashno M
    Mol Neurobiol; 2022 Sep; 59(9):5253-5262. PubMed ID: 35665903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
    Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y
    Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson's disease.
    Mohammed OA; Elballal MS; El-Husseiny AA; Khidr EG; El Tabaa MM; Elazazy O; Abd-Elmawla MA; Elesawy AE; Ibrahim HM; Abulsoud AI; El-Dakroury WA; Abdel Mageed SS; Elrebehy MA; Nomier Y; Abdel-Reheim MA; El-Husseiny HM; Mahmoud AMA; Saber S; Doghish AS
    Pathol Res Pract; 2024 Jan; 253():155023. PubMed ID: 38081104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
    Miraglia F; Betti L; Palego L; Giannaccini G
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases.
    Maniati MS; Maniati M; Yousefi T; Ahmadi-Ahangar A; Tehrani SS
    J Cell Biochem; 2019 Jun; 120(6):8908-8918. PubMed ID: 30663117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
    Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraquat and MPTP induce alteration in the expression profile of long noncoding RNAs in the substantia nigra of mice: Role of the transcription factor Nrf2.
    Wang L; Yang H; Wang Q; Zhang Q; Wang Z; Zhang Q; Wu S; Li H
    Toxicol Lett; 2018 Jul; 291():11-28. PubMed ID: 29627306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.
    Manna I; Quattrone A; De Benedittis S; Iaccino E; Quattrone A
    J Parkinsons Dis; 2021; 11(4):1475-1489. PubMed ID: 34334422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant Role of Long Non-coding RNAs in Parkinson's Disease.
    Na C; Wen-Wen C; Li W; Ao-Jia Z; Ting W
    Curr Pharm Des; 2022; 28(37):3085-3094. PubMed ID: 36154598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Role of Autophagy-Associated lncRNAs in the Pathogenesis of Neurodegenerative Diseases.
    Jiang Y; Xu N
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease.
    Rezaei O; Nateghinia S; Estiar MA; Taheri M; Ghafouri-Fard S
    Eur J Pharmacol; 2021 Apr; 896():173914. PubMed ID: 33508286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal dysregulation of long non-coding RNAs in Parkinson's disease.
    Müller-Nedebock AC; Cuttler K; Pfaff AL; Kõks S
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1780-1784. PubMed ID: 37750041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.